Rein Therapeutics Inc.
RNTX
$0.92
-$0.03-2.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.45M | 3.22M | 4.05M | 5.72M | 7.43M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.01M | 1.11M | 1.13M | 880.00K | 903.00K |
| Total Current Assets | 5.45M | 4.33M | 5.17M | 6.60M | 8.33M |
|
|
|||||
| Total Current Assets | 5.45M | 4.33M | 5.17M | 6.60M | 8.33M |
| Net Property, Plant & Equipment | -- | -- | -- | 1.00K | 1.00K |
| Long-term Investments | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
| Goodwill | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
| Total Other Intangibles | 13.50M | 13.50M | 42.20M | 42.20M | 42.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.01M | 2.00K | 2.00K | 2.35M | 766.00K |
| Total Assets | 26.29M | 24.16M | 53.71M | 57.48M | 57.63M |
|
|
|||||
| Total Accounts Payable | 6.26M | 3.98M | 4.12M | 6.03M | 1.15M |
| Total Accrued Expenses | 2.28M | 2.11M | 1.51M | 1.48M | 4.66M |
| Short-term Debt | 4.92M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 176.00K | 98.00K | 114.00K | 183.00K | 164.00K |
| Total Other Current Liabilities | 176.00K | 98.00K | 114.00K | 183.00K | 164.00K |
| Total Current Liabilities | 13.64M | 6.18M | 5.74M | 7.69M | 5.98M |
|
|
|||||
| Total Current Liabilities | 13.64M | 6.18M | 5.74M | 7.69M | 5.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.92M | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.06M | 1.06M | 1.77M | 1.77M | 1.77M |
| Total Liabilities | 14.70M | 7.24M | 7.52M | 9.47M | 7.75M |
|
|
|||||
| Common Stock & APIC | 373.76M | 373.25M | 370.53M | 366.75M | 361.81M |
| Retained Earnings | -407.11M | -401.27M | -369.30M | -363.72M | -356.90M |
| Treasury Stock & Other | -62.00K | -62.00K | -44.00K | -22.00K | -32.00K |
| Total Common Equity | -33.41M | -28.09M | 1.19M | 3.01M | 4.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
|
|
|||||
| Total Common Equity | -33.41M | -28.09M | 1.19M | 3.01M | 4.87M |
| Total Preferred Equity | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.59M | 16.92M | 46.19M | 48.01M | 49.88M |
|
|
|||||